<?xml version="1.0" encoding="UTF-8"?>
<p>The, 6–8-week-old male BALB/c mice (FSRI SRC VB “VECTOR”, Koltsovo, Russia) were randomly distributed into 3 groups (
 <italic>n</italic> = 10 per group). Mice were twice (prime boost) immunized subcutaneously (i.s.) with 0.25 mL Ultrix
 <sup>®</sup> vaccine (SPBNIIVS, Saint Petersburg, Russia) containing purified surface antigens from the influenza strain B/Colorado/06/2017 (lineage B/Victoria/2/87).
</p>
